To improve is to change, so to be perfect is to have changed often. with ARI ratios <0.6 had significantly elevated mortality at 1 year, indicating that an ARI ratio $0.6 in this setting is relatively reassuring and raises the threshold for additional maneuvers to reduce PVR, including post-dilation and transcatheter valve-intranscatheter valve therapy, which carry potential risk.
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To improve is to change, so to be perfect is to have changed often. Moreover, the advent of new TAVR devices such as the SAPIEN 3 (Edwards Lifesciences, Irvine, California) appears to have substantially reduced the frequency of moderate PVR (7) , but even with these advances, there remains a substantial percentage of patients with mild PVR, which could still be prognostically significant, particularly with the treatment of younger, lower surgical risk TAVR candidates (7) . PVR is extremely difficult to quantify, particularly in the intermediate (mild to moderate) range of severity, and despite several attempts to do so reliably using many different imaging modalities, including transthoracic echocardiography, transesophageal echocardiography, and angiography, the reproducibility and reliability of findings remain limited, even when evaluated at experienced core laboratories. Magnetic resonance imaging is an accurate modality in the outpatient setting but is for the most part not feasible periprocedurally to guide management.
It was for these reasons that Sinning et al. (8) devised in 2012 the aortic regurgitation index (ARI) with the use of transcatheter hemodynamic monitoring to guide the need for immediate therapeutic maneuvers to ameliorate PVR. They subsequently validated these data in an additional multicenter study (9) and other investigators further showed its clinical merit, with the addition of heart rate adjustment to the algorithm in some series (10, 11) . Medtech; and is an inventor of intellectual property for TAVR hemodynamic monitoring (TAVR pressure wire).
volume of contrast used, longer procedure times, more bradycardia, and new pacemakers and was also an independent predictor of late cardiovascular mortality. That said, it is crucial that patients not be left with hemodynamically significant PVR, as data have shown that they will often succumb to this and experience prognostically important heart failure, if not immediately then in the ensuing months post-procedure.
The ARI ratio is an important step forward in evaluating not only the hemodynamic severity of PVR seen after TAVR but also a patient's ability to tolerate PVR, adjusting for important confounders and placing the data in the context of the pre-TAVR hemodynamic state; as the investigators (12) The other crucial omission from the ARI and the ARI ratio is the influence of heart rate. The simple fact remains that lower heart rates reduce the difference in left ventricular and aortic diastolic pressures (diastolic delta) with the prolongation of diastole, while higher heart rates shorten diastole and increase the diastolic delta. The investigators (12) do acknowledge the important influence of heart rate and suggest that the ARI parameter should be measured at a heart rate of 60 to 80 beats/min, pacing if lower heart rates are encountered, but it is not unusual to encounter a heart rate post-TAVR of 80 beats/min or higher, and more important, a change from 60 to 80 beats/min or vice versa will dramatically alter the ARI.
Although the investigators (12) state that the discriminatory value of the ARI ratio could not be increased by heart rate adjustment, in the absence of receiver-operating characteristic curve analysis, this is not well substantiated. Moreover, it would be of interest to see what removing their denominator of systolic blood pressure from the ARI does objectively to its prognostic value. There is clearly room for some improvement, as the survival of the "reduced ARI but favorable" group (ARI <25 with ARI ratio $0.6) is far from superimposed on the Kaplan-Meier curve, with almost twice the 1-year mortality compared with those with ARI values $25 (Figure 3 ). There is some discussion of other parameters accounting for the influence of heart rate, including the diastolic/ systolic pressure-time integral (10), the composite heart rate-adjusted hemodynamic-echocardiographic aortic insufficiency score (11) , and the time-integrated aortic regurgitation index (17), but it is stated that these "increased accuracy at the price of losing simplicity and straightforwardness, since they cannot be calculated without a computer in the acute implantation setting" (12) .
In the catheterization laboratory, we do not calcu- Perfecting Transcatheter Aortic Valve Hemodynamics
